Top 3 Coronavirus Vaccines Compare

Coronavirus-Vaccines-Compare

Coronavirus vaccines compare –  Pfizer, Moderna, and AstraZeneca.

AstraZeneca- On 14th December the pharmaceutical company AstraZeneca’s announced that its vaccine successfully prevented coronavirus infection, 3 candidates appear to be promising vital tools to curtail the COVID-19 pandemic.

Last week Drug company partners Pfizer and BioNTech and Biotech firm Moderna announced that their vaccines were ready to submit to the US Food and Drug Administration (FDA) for emergency use authorization.

Pfizer vaccine is already being administered in the US and another Moderna could be approved for use by the end of the week, and the third AstraZeneca is coming soon. More data will be available in the upcoming weeks when companies take their applications to the Food and Drug Administration.

Till then, here is a closer look at all three coronavirus vaccines based on the limited information presented in company press releases.

Coronavirus Vaccines Compare

PfizerModernaAstraZeneca
How it worksMessenger RNA (mRNA)Messenger RNA  (mRNA)Inactivated cold virus
Shots do you needYou need 2 doses, three weeks apartTwo doses, four weeks apart2 doses, four weeks apart
Side effectsHeadache, muscle pain, fatigue, fevers, chills, especially after the second dose. Muscle aches, fever, headaches lasting a few days. Effects worse after the second dose.Not yet known
Safety There are no major safety problems in this vaccineNo concern according to the companyThere is no safety concern
What % of people did it protect from becoming infected in clinical studies?95% in their clinical trials94.1% in their clinical trials70% in their clinical trials
How many Dose will be available50 million20 million3 billion planned for 2021
AvailabilityStarting  14th Dec, 1.3 billion in 2021Starting 21st Dec, 80 million for the US in 20212021
Approval /expected approvalGranted emergency use authorization on 11th Dec.Advisory committee meeting17th  Dec; approval expected 24 to 48 hours afterHas not submitted an application for emergency use authorization in the U.S.

Source-www.webmd.com and Online News

Exit mobile version